Want to join the conversation?
$JPM's Commercial Banking segment posted 2Q16 net income of nearly $700MM on revenue of $1.8Bil and an ROE of 16%. IB revenue rebounded from 1Q16, up 23% sequentially and flat YonY. The company continued to see strong momentum in loan growth, with average loan balances up 13% YonY. C&I loans were up 9% for the quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?